Yunzhi Guben Gao ameliorates immunosuppression via a ligilactobacillus-driven isovaleric acid axisOA
Yunzhi Guben Gao ameliorates immunosuppression via a ligilactobacillus-driven isovaleric acid axis
Si Wang;You Lv;Yan-Ling Jin;Zhu-Quan Zhang;Lin-Yu Tang;Jing-Hua Wang;Jia-Bao Liao;Xue-Hua Xie;Hong-Yi Liu
The Second Affiliated Hospital,Yunnan University of Chinese Medicine,Kunming 650021,ChinaCollege of Basic Medical,Yunnan University of Chinese Medicine,Kunming 650500,ChinaCollege of Basic Medical,Yunnan University of Chinese Medicine,Kunming 650500,ChinaCollege of Basic Medical,Yunnan University of Chinese Medicine,Kunming 650500,ChinaCollege of Traditional Chinese Medicine,Yunnan University of Chinese Medicine,Kunming 650500,ChinaInstitute of Nature and Ecology,Heilongjiang Academy of Sciences,Harbin 150000,ChinaThe First Affiliated Hospital,Yunnan University of Chinese Medicine,Kunming 650021,ChinaThe First Affiliated Hospital,Yunnan University of Chinese Medicine,Kunming 650021,ChinaThe First Affiliated Hospital,Yunnan University of Chinese Medicine,Kunming 650021,China
Ligilactobacillusisovaleric acidimmunosuppressionmicrobiota-metabolite-immune axisYunzhi Guben Gao
Ligilactobacillusisovaleric acidimmunosuppressionmicrobiota-metabolite-immune axisYunzhi Guben Gao
《传统医学研究（英文版）》 2026 (5)
53-67,15
This research was supported by the Research Fund Project of the Education Department of Yunnan Province(No.2023Y0464),Research Project for Scientific Research Funds of Provincial Research Institutions in Heilongjiang Province(No.CZBZ2025ZR003).The authors would like to thank Shanghai Meiji Biomedical Technology Co.,Ltd.for performing the intestinal flora assay and BioRender.com for assistance with figure preparation.
评论